ERBB2 and breast carcinoma: While most of the lncRNAs expression were not significantly altered among HER2 negative and HER2 positive breast cancer tissues in our study, PVT1 showed significantly lower expression in HER2 positive and p53 positive patients (P = 0.001, P = 0.006)(Figure 4).